ProEncía Biotechnology

📍 Minneapolis, United States👥 5 employees💰 Last funded May 2025
Pharmaceutical Manufacturing
LinkedIn
ProEncía Biotechnology, a Minnesota-based innovative periodontal care company, is committed to fighting periodontal disease through unique, ground-breaking treatments. The company has developed multiple products, including an OTC prophylactic and an RX therapeutic, to regenerate and restore oral tissue health.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ProEncía Biotechnology?
ProEncía Biotechnology has 1 investors on record on gritt.io.
When did ProEncía Biotechnology last raise funding?
The most recent investment in ProEncía Biotechnology recorded on gritt.io was in May 2025.
What industry is ProEncía Biotechnology in?
ProEncía Biotechnology operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is ProEncía Biotechnology based?
ProEncía Biotechnology is headquartered in Minneapolis, United States.